Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Tablet testing HPLC

Metaprolol tartrate tablet testing uses UV and IR spectroscopy for metaprolol ID, TLC for the tartrate ion ID, and HPLC retention time for identification. The IR spectroscopy test is carried out by dissolving approximately 136 mg of finely ground tablets and in 25 mL of water with 4 mL of ammonium hydroxide (1 3). After extraction with chloroform, the organic layer is dried over anhydrous sodium sulfate, evaporated, and placed in a freezer to congeal... [Pg.329]

Application of DSC and HPLC to determine the effects of mixture composition and preparation during the evaluation of niclosamide-excipients compatibility showed that although some reactions occurred, niclosamide was compatible with a majority of common tablet excipients tested [63],... [Pg.87]

Most manufacturers of dissolution testing devices offer semi-automated systems that can perform sampling, filtration, and UV reading or data collection. These systems automate only a single test at a time. Fully automated systems typically automate entire processes including media preparation, media dispensing, tablet or capsule drop, sample removal, filtration, sample collection or analysis (via direct connection to spectrophotometers or HPLCs), and wash cycles. A fully automated system allows automatic performance of a series of tests to fully utilize unused night and weekend instrument availability. [Pg.271]

Accuracy is defined as the bias of the method, it is a measure of how close the observed result is to the specified quantity. It is usually tested using a method of spiked placebos or of standard addition [3,4]. The expected performance of a method with respect to its accuracy varies enormously from sample to sample. A simple drug formulation, such as a tablet or injection, assayed by HPLC can expect an accuracy of around +/- 1%. [Pg.193]

General information Product, including description (e.g., tablet, dose) method name, including revision and technique (e.g., HPLC) project information concerning sample(s) (e.g., stability samples three months) date of test and lot number equipment identifier column raw data file name of computerized system and analyst. This general information will be transferred to each spreadsheet. [Pg.293]

Purity and potency are two of the metrics that pharmaceutical quality assurance (QA) departments emphasize to determine if a batch may be released. To do this they typically employ HPLC and/or mass spectrometry to determine gross composition, and to verify the absence of any contaminants. However, only a small subset of tablets in a batch is tested because the tests destroy the sample. While these methods offer some insight into sample consistency, they provide no information on the distribution of the components in an individual finished form. Dissolution testing is used to indicate the manner and... [Pg.188]

The concentration profile during the dissolution testing of melphalan tablets in water and simulated gastric fluid was determined by HPLC. A method of data analysis was developed to take into account the spontaneous drug degradation [111]. [Pg.295]

The determination of compound X and its related compounds in product X tablets will be validated according to the tests described in this protocol. The chromatographic parameters for these experiments are as stated in the method, HPLC Assay and determination of related compounds in product X tablets. ... [Pg.162]

In order to identify any excipient- and packaging-related impurities in the formulation, placebo cores and hlm-coated placebos, were prepared using the same excipients as in the active tablets. The placebo cores and film-coated placebos, as well as active cores and hlm-coated active tablets were set up on a stability study in high density polyethylene (HDPE) bottles with and without desiccant and in foil-foil blisters. At the designated time intervals, the tablets were tested for purity by gradient HPLC analysis. [Pg.246]

Different types of syringe filters were then evaluated to try to remove the problematic excipients. Figure 10.4c shows that the use of an Amicon Ultra-4 centrifugal filter (Millipore, Billerica, MA) removed the residual HPMC from the sample solution but did not remove the starch. The Amicon Ultra-4 filter, however, does introduce later eluting filter-related peaks that fortunately do not interfere with any components of interest. Starch was not removed by any of the filters tested. As a result, excipient placebo samples were used as part of the method. These placebo samples were extracted and injected onto the HPLC system to confirm which peaks in the fixed combination tablet samples were excipient-related and these peaks were not quantitated or reported as drug-related degradants. [Pg.253]

Alpdogan and Sungur [50] developed an indirect atomic absorption spectroscopy method for the determination of mefenamic and flufenamic acids, and diclofenac sodium, based on the complexation with copper (II) amine sulfate. The complex was extracted into chloroform, and the concentrations of substances were determined indirectly by AAS measurement of copper after re-extraction into 0.3 N nitric acid solution. The developed method was applied to the assay of the substances in commercial tablet formulations. The results were statistically compared with those obtained by HPLC method by t- and F tests at 95% confidence level. Calculated t and F values were both lower than the table values. [Pg.303]

A spectrum in a specified ranalogue signals from eadi photodiode are digitised and transferred to a computer, where they e corrected for dark current response and transformed to absorbance. A number of digital techniques are available to increase sensitivity and to extend the use of rapid-scanning detectors to multicomponent analysis, reaction kinetics, tablet dissolution tests, process control, and detection in HPLC (A. F. Fell et al, Chrom-atographia, 1982, 16, 69-78). [Pg.226]

The list below is a summary of test methods that are most likely to be required during the testing of most common dosage forms (tablets, capsules, and solutions). The list is by no means an exhaustive (since test methods to determine moisture content, pH, sterility, particulate matter, and microbial testing are not listed) and the selection of test methods depends on an evaluation of a dosage form and also on the phase of drug development. For each type of test, most common techniques utilized are listed in square brackets. As can be seen, HPLC can be employed for aU of the following test methods. [Pg.686]

Drennen and Lodder reported a non-destructive NIRS method to monitor the decomposition of aspirin. In contrast to the multi step HPLC assay for salicylic acid and the USP identity tests for aspirin, the NIR method involved a 90s scan of individual intact aspirin tablets. The workers correlated changes... [Pg.3637]

A typical electropherogram is shown in Fig. 2, which indicates no interferences from the tablet excipients. In order to examine the applicability and validity of the CE method, ENX pharmaceutical tablets were analyzed by CE and HPLC methods. Results of the comparative studies are shown in Table 4. The results indicate that both methods, i.e., by CE and HPLC, show insignificant differences at the 95% probabihty level and the ENX tablet formulations satisfy the official requirements. Certain experiments were conducted to elucidate the recovery of ENX and to validate the CE studies. Three sets of experiments with definite amounts of ENX were added to the serum and to the double-distiUed water, and were analyzed. The same experiment was also performed without any ENX. The recovery was found to be 89.7 0.63 (RSD%). The recovery experiments were also tested by HPLC and were found to be 78.8 4.94 (RSD%). The difference between the methods could be due to the different precipitation procedures applied. [Pg.640]

Stability testing of indapamide tablets is accomplished by an HPLC assay and dissolution testing. The conditions for the HPLC assay are described in the section for potency assay (9.2.1). The dissolution test methodology is described in Section 9.1. [Pg.265]


See other pages where Tablet testing HPLC is mentioned: [Pg.102]    [Pg.749]    [Pg.50]    [Pg.171]    [Pg.259]    [Pg.262]    [Pg.35]    [Pg.442]    [Pg.384]    [Pg.395]    [Pg.246]    [Pg.187]    [Pg.659]    [Pg.110]    [Pg.235]    [Pg.40]    [Pg.261]    [Pg.385]    [Pg.255]    [Pg.406]    [Pg.153]    [Pg.248]    [Pg.46]    [Pg.719]    [Pg.50]    [Pg.3632]    [Pg.3637]    [Pg.504]    [Pg.47]    [Pg.238]   
See also in sourсe #XX -- [ Pg.3708 ]




SEARCH



Tablet testing

© 2024 chempedia.info